跳至主要内容
临床试验/JPRN-UMIN000003972
JPRN-UMIN000003972已完成未知

A study on the utility of TAZ/PIPC in the treatment of nosocomial pneumonia - Comparison with MEPM - - A study on the utility of TAZ/PIPC in the treatment of nosocomial pneumonia - Comparison with MEPM

Department of Infection Control and Prevention, Aichi Medical University Hospital0 个研究点目标入组 160 人开始时间: 2010年7月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients with a history of hypersensitivity to the ingredients of this product, such as shock (2) Children (younger than 16 years old) (3) Patients with infectious mononucleosis (4) Patients receiving sodium valproate (5) Pregnant women, lactating women, or patients possibly to be pregnant (6) Patients with hepatic, renal or cardiac diseases, immunodeficiency, other serious underlying diseases or complications, who have difficulty in evaluation of the efficacy of this product. (7) Patients in the group with severe disease (C group), for whom combination with antimicrobial agents is recommended in the guidelines for treatment of nosocomial pneumonia of the Japanese Respiratory Society (8) Other patients judged to be unsuitable as subjects by the physicians in charge

研究者

发起方
Department of Infection Control and Prevention, Aichi Medical University Hospital

相似试验